Cravath’s New York Office Moves to Two Manhattan West
Cravath has been a leading advisor to a broad array of financial institutions, insurers and reinsurers for decades, including in some of the largest and most important transactions and cases in recent history. Our clients include commercial banks, including both U.S. and non-U.S. money‑center banks and large U.S. regional banks, investment banks, broker‑dealers, non‑traditional lending sources, fintech companies and non-bank firms, private equity funds, hedge funds, asset managers and investment advisors. We also represent diversified insurance and related financial services companies and leaders in the property and casualty insurance and reinsurance markets.
Our transactional capabilities include representing these clients, or their boards of directors, in connection with mergers, acquisitions, divestitures, spin-offs, regulatory matters, bank financings and capital market activities, as well as environmental, social and governance (“ESG”) considerations. Over the years, we have advised on groundbreaking deals employing first-use structures, handled critical transactions and assisted companies in navigating some of the most significant financial crises and post-crisis matters in this sector.
Our litigators routinely tackle the largest and most significant cases in the industry, representing financial institutions (or their outside directors or special committees) in securities class actions—including serving as nationwide coordinating counsel—antitrust class actions, RICO class actions, mergers & acquisitions litigation, bankruptcy litigation and shareholder derivative actions, as well as litigation arising under the Alien Tort Statute and matters involving non-U.S. law. Our litigators handle matters at the trial and appellate levels, in arbitrations and before government and regulatory bodies. In addition, our investigations team is a trusted advisor to financial institutions, their boards of directors and their senior executives regarding internal and government investigations, regulatory enforcement proceedings and white collar criminal defense matters involving the full range of corporate crises.
Our transactional capabilities include representing these clients, or their boards of directors, in connection with mergers, acquisitions, divestitures, spin-offs, regulatory matters, bank financings and capital market activities, as well as environmental, social and governance (“ESG”) considerations. Over the years, we have advised on groundbreaking deals employing first-use structures, handled critical transactions and assisted companies in navigating some of the most significant financial crises and post-crisis matters in this sector.
Our litigators routinely tackle the largest and most significant cases in the industry, representing financial institutions (or their outside directors or special committees) in securities class actions—including serving as nationwide coordinating counsel—antitrust class actions, RICO class actions, mergers & acquisitions litigation, bankruptcy litigation and shareholder derivative actions, as well as litigation arising under the Alien Tort Statute and matters involving non-U.S. law. Our litigators handle matters at the trial and appellate levels, in arbitrations and before government and regulatory bodies. In addition, our investigations team is a trusted advisor to financial institutions, their boards of directors and their senior executives regarding internal and government investigations, regulatory enforcement proceedings and white collar criminal defense matters involving the full range of corporate crises.
Deals & Cases
June 14, 2024
Cravath represented the European Investment Bank in connection with its $1 billion registered SOFR floating rate notes offering. The purpose of the European Investment Bank is to contribute to the balanced and steady development of the internal market among Member States of the European Union. The notes were listed on the Luxembourg Stock Exchange. The transaction closed on May 30, 2024.
Deals & Cases
June 04, 2024
Cravath represented the underwriters in connection with the $1 billion registered senior notes offering of LPL Holdings, Inc., a holding company which, through its securities brokerage, offers investment advisory services and insurance brokerage services. The transaction closed on May 20, 2024.
Deals & Cases
May 30, 2024
Cravath represented the underwriters in connection with the $600 million registered senior notes offering of Markel Group Inc. Markel Group Inc. markets and underwrites specialty insurance products in the United States and internationally. The transaction closed on May 16, 2024.
Deals & Cases
May 28, 2024
Cravath represented the underwriters in connection with the $1.75 billion registered fixed rate/floating rate senior notes offering of The PNC Financial Services Group, Inc., one of the largest diversified financial services companies in the United States. The transaction closed on May 14, 2024.
Deals & Cases
May 17, 2024
On May 13, 2024, the U.S. District Court for the Southern District of Texas dismissed claims brought by the Federal Trade Commission (“FTC”) against private equity firm Welsh Carson relating to U.S. Anesthesia Partners’ (“USAP”) acquisition of anesthesiology practices in Texas, and other allegedly anticompetitive conduct. In a novel approach, the FTC had named both USAP and Welsh Carson, a minority investor, as defendants in the case. On behalf of Cravath client American Investment Council, Cravath submitted an amicus brief in support of Welsh Carson’s motion to dismiss.
Accolades
June 18, 2024
On June 14, 2024, Cravath partners Michael A. Paskin, George E. Zobitz, Paul H. Zumbro, Jelena McWilliams, Lauren A. Moskowitz and Omid H. Nasab were named to Lawdragon’s list of “500 Leading Global Bankruptcy and Restructuring Lawyers” in recognition of their work advising clients on financial restructuring and reorganization and related litigation matters. The list recognizes the lawyers “who can make all the difference for a business, debtor or creditor and have done so time and time again.”
Accolades
June 13, 2024
The IAM Patent 1000 2024, which recognizes the firms and individuals “deemed outstanding in the pivotal area of patent law,” ranked Cravath in the top tier for New York across Litigation and Transactions. In addition, Cravath partners Keith R. Hummel, David J. Kappos, David R. Marriott, Sasha Rosenthal‑Larrea and Sharonmoyee Goswami were recognized for their “outstanding service” and representation of clients on litigation and transactional matters including Johnson & Johnson in its $16.6 billion acquisition of Abiomed; Abiomed in its victory before the U.S. Patent Trial and Appeal Board; and Truist Bank in patent infringement litigation brought by United Services Automobile Association.
Accolades
June 13, 2024
The 2024 edition of The Legal 500 United States ranked Cravath in the top tier nationally in 16 areas: Antitrust - Civil Litigation/Class Actions: Defense; Capital Markets: Debt Offerings (Advice to Issuers); Capital Markets: Debt Offerings (Advice to Underwriters); Capital Markets: Global Offerings (Advice to Issuers); Capital Markets: Global Offerings (Advice to Underwriters); Commercial Lending (Advice to Lenders); Employee Benefits, Executive Compensation and Retirement Plans: Transactional; Environment: Transactional; Financial Services Litigation; Fintech (Crypto); General Commercial Disputes; International Tax; M&A: Large Deals ($1bn+); M&A Litigation: Defense; Securities Litigation: Defense; and U.S. Taxes: Non‑contentious. In addition, 75 Cravath attorneys were individually recognized by The Legal 500 United States this year.
Activities & Publications
June 11, 2024
On June 6, 2024, Cravath partners John W. White and Jennifer S. Leete participated in the 42nd Annual SEC and Financial Reporting Institute Conference, which was co‑hosted by the University of Southern California’s Leventhal School of Accounting and Financial Executives International in Los Angeles. The conference featured business and accounting executives and leading professionals from the U.S. Securities and Exchange Commission, the Financial Accounting Standards Board and Public Company Accounting Oversight Board to discuss recent SEC and financial reporting issues. John is Chair of the Institute’s Advisory Board.
Activities & Publications
June 06, 2024
Cravath partner Nicholas A. Dorsey and of counsel Virginia M. Anderson co‑authored the U.S. Law & Practice chapter of the Chambers Venture Capital Guide, which was published in May 2024. The guide, which is part of the publisher’s Global Practice Guides series, provides the latest legal information on trends in the venture capital market; fund structures, economics and regulation; investments in VC companies; government subsidies and tax; and employee incentivization in the 20 jurisdictions covered. The U.S. Law & Practice chapter examined the increase in U.S. venture capital funding in artificial intelligence in 2023; the emergence of “down round” raises, bridge financing solutions and alternative financing solutions for companies that have faced financing challenges; typical venture capital fund structure in the U.S.; and more.
Deals & Cases
June 14, 2024
Cravath represented the European Investment Bank in connection with its $1 billion registered SOFR floating rate notes offering. The purpose of the European Investment Bank is to contribute to the balanced and steady development of the internal market among Member States of the European Union. The notes were listed on the Luxembourg Stock Exchange. The transaction closed on May 30, 2024.
Deals & Cases
June 04, 2024
Cravath represented the underwriters in connection with the $1 billion registered senior notes offering of LPL Holdings, Inc., a holding company which, through its securities brokerage, offers investment advisory services and insurance brokerage services. The transaction closed on May 20, 2024.
Deals & Cases
May 30, 2024
Cravath represented the underwriters in connection with the $600 million registered senior notes offering of Markel Group Inc. Markel Group Inc. markets and underwrites specialty insurance products in the United States and internationally. The transaction closed on May 16, 2024.
Deals & Cases
May 28, 2024
Cravath represented the underwriters in connection with the $1.75 billion registered fixed rate/floating rate senior notes offering of The PNC Financial Services Group, Inc., one of the largest diversified financial services companies in the United States. The transaction closed on May 14, 2024.
Deals & Cases
May 17, 2024
On May 13, 2024, the U.S. District Court for the Southern District of Texas dismissed claims brought by the Federal Trade Commission (“FTC”) against private equity firm Welsh Carson relating to U.S. Anesthesia Partners’ (“USAP”) acquisition of anesthesiology practices in Texas, and other allegedly anticompetitive conduct. In a novel approach, the FTC had named both USAP and Welsh Carson, a minority investor, as defendants in the case. On behalf of Cravath client American Investment Council, Cravath submitted an amicus brief in support of Welsh Carson’s motion to dismiss.
Accolades
June 18, 2024
On June 14, 2024, Cravath partners Michael A. Paskin, George E. Zobitz, Paul H. Zumbro, Jelena McWilliams, Lauren A. Moskowitz and Omid H. Nasab were named to Lawdragon’s list of “500 Leading Global Bankruptcy and Restructuring Lawyers” in recognition of their work advising clients on financial restructuring and reorganization and related litigation matters. The list recognizes the lawyers “who can make all the difference for a business, debtor or creditor and have done so time and time again.”
Accolades
June 13, 2024
The IAM Patent 1000 2024, which recognizes the firms and individuals “deemed outstanding in the pivotal area of patent law,” ranked Cravath in the top tier for New York across Litigation and Transactions. In addition, Cravath partners Keith R. Hummel, David J. Kappos, David R. Marriott, Sasha Rosenthal‑Larrea and Sharonmoyee Goswami were recognized for their “outstanding service” and representation of clients on litigation and transactional matters including Johnson & Johnson in its $16.6 billion acquisition of Abiomed; Abiomed in its victory before the U.S. Patent Trial and Appeal Board; and Truist Bank in patent infringement litigation brought by United Services Automobile Association.
Accolades
June 13, 2024
The 2024 edition of The Legal 500 United States ranked Cravath in the top tier nationally in 16 areas: Antitrust - Civil Litigation/Class Actions: Defense; Capital Markets: Debt Offerings (Advice to Issuers); Capital Markets: Debt Offerings (Advice to Underwriters); Capital Markets: Global Offerings (Advice to Issuers); Capital Markets: Global Offerings (Advice to Underwriters); Commercial Lending (Advice to Lenders); Employee Benefits, Executive Compensation and Retirement Plans: Transactional; Environment: Transactional; Financial Services Litigation; Fintech (Crypto); General Commercial Disputes; International Tax; M&A: Large Deals ($1bn+); M&A Litigation: Defense; Securities Litigation: Defense; and U.S. Taxes: Non‑contentious. In addition, 75 Cravath attorneys were individually recognized by The Legal 500 United States this year.
Activities & Publications
June 11, 2024
On June 6, 2024, Cravath partners John W. White and Jennifer S. Leete participated in the 42nd Annual SEC and Financial Reporting Institute Conference, which was co‑hosted by the University of Southern California’s Leventhal School of Accounting and Financial Executives International in Los Angeles. The conference featured business and accounting executives and leading professionals from the U.S. Securities and Exchange Commission, the Financial Accounting Standards Board and Public Company Accounting Oversight Board to discuss recent SEC and financial reporting issues. John is Chair of the Institute’s Advisory Board.
Activities & Publications
June 06, 2024
Cravath partner Nicholas A. Dorsey and of counsel Virginia M. Anderson co‑authored the U.S. Law & Practice chapter of the Chambers Venture Capital Guide, which was published in May 2024. The guide, which is part of the publisher’s Global Practice Guides series, provides the latest legal information on trends in the venture capital market; fund structures, economics and regulation; investments in VC companies; government subsidies and tax; and employee incentivization in the 20 jurisdictions covered. The U.S. Law & Practice chapter examined the increase in U.S. venture capital funding in artificial intelligence in 2023; the emergence of “down round” raises, bridge financing solutions and alternative financing solutions for companies that have faced financing challenges; typical venture capital fund structure in the U.S.; and more.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.